The biopharmaceutical industry is rapidly advancing with the development of innovative therapies that offer greater precision, improved efficacy, and enhanced safety profiles. Among these innovations, antibody fragments have emerged as a promising class of biologics due to their smaller size, improved tissue penetration, and ability to target disease-specific biomarkers. Growing demand...
Bangla